EEF1E1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.096000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.351000E-01
Normal-vs-Stage2
7.881800E-01
Normal-vs-Stage3
9.997000E-01
Normal-vs-Stage4
1.497010E-01
Stage1-vs-Stage2
5.489600E-01
Stage1-vs-Stage3
5.543000E-01
Stage1-vs-Stage4
5.647600E-01
Stage2-vs-Stage3
7.590400E-01
Stage2-vs-Stage4
2.257000E-01
Stage3-vs-Stage4
2.620000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.577600E-01
Normal-vs-AfricanAmerican
5.000800E-01
Normal-vs-Asian
6.468800E-01
Caucasian-vs-AfricanAmerican
9.798400E-01
Caucasian-vs-Asian
1.144230E-01
AfricanAmerican-vs-Asian
2.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.215400E-01
Normal-vs-Female
6.805200E-01
Male-vs-Female
8.712000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.412200E-01
Normal-vs-Age(41-60Yrs)
6.157600E-01
Normal-vs-Age(61-80Yrs)
8.062800E-01
Normal-vs-Age(81-100Yrs)
3.335200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.619000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.317800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.565600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.697200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.773580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.843500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.209000E-01
Normal-vs-Daily Drinker
8.534600E-01
Normal-vs-Weekly Drinker
4.376600E-01
Normal-vs-Occasional Drinker
5.252600E-01
Normal-vs-Social Drinker
7.405200E-01
Non Drinker-vs-Daily Drinker
1.487800E-01
Non Drinker-vs-Weekly Drinker
9.698000E-01
Non Drinker-vs-Occasional Drinker
9.111400E-01
Non Drinker-vs-Social Drinker
5.641400E-01
Daily Drinker-vs-Weekly Drinker
2.887600E-01
Daily Drinker-vs-Occasional Drinker
1.216430E-01
Daily Drinker-vs-Social Drinker
3.885800E-01
Weekly Drinker-vs-Occasional Drinker
9.039000E-01
Weekly Drinker-vs-Social Drinker
6.888200E-01
Occasional Drinker-vs-Social Drinker
4.634800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.099800E-01
Normal-vs-Grade 2
9.149200E-01
Normal-vs-Grade 3
9.487000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.221000E-01
Grade 1-vs-Grade 3
5.468600E-01
Grade 1-vs-Grade 4
9.099800E-01
Grade 2-vs-Grade 3
4.687600E-01
Grade 2-vs-Grade 4
9.149200E-01
Grade 3-vs-Grade 4
9.487000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.458400E-01
Normal-vs-NonDiabetic
6.986000E-01
Diabetic-vs-NonDiabetic
5.917600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.624400E-01
Normal-vs-NoPancreatitis
6.772200E-01
Pancreatitis-vs-NoPancreatitis
2.034200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.620000E-01
Normal-vs-N1
7.932800E-01
N0-vs-N1
1.478620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.459000E-01
Normal-vs-TP53-NonMutant
5.958800E-01
TP53-Mutant-vs-TP53-NonMutant
3.718800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
